ClinicalTrials.gg
RecruitingNCT06397794Updated Jun 17, 2026

Navigating Pregnancy and Parenthood With Lyme Disease

An observational study in Lyme Disease, Post Treatment Lyme Disease and Chronic Lyme Disease, sponsored by Children's National Research Institute. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-17.

Primary conditionPost-Lyme Disease SyndromeRegistry: Lyme DiseaseReclassifiedWhy we changed it
Registry
Lyme Disease — the first condition term the registry derived for this study.
ClinicalTrials.gg
Post-Lyme Disease Syndrome
Why
  1. The study's listed conditions name Post-Lyme Disease Syndrome, a narrower term within Lyme Disease.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Children's National Research Institute · Observational

How we know

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
30
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Post-Lyme Disease Syndrome with a site in United States — 9 open to participants now, 9 under way, none of them phase 3. Post-Lyme Disease Syndrome · United States.

Started
2024
with 2 others
Observational
6 of 19
4 open now
Registered
13th of 19
by date
Lead sponsor
2 of 19
Children's National Research Institute

Among the 19 studies in Post-Lyme Disease Syndrome with a site in United States, this one is one of 3 that started in 2024, is one of 6 observational ones, and was the 13th registered.

Post-Lyme Disease Syndrome

22 studies on the registry are indexed under Post-Lyme Disease Syndrome; 9 are open to participants now.

Browse Post-Lyme Disease Syndrome studies →

Open to participants now

9 of the 19 studies in Post-Lyme Disease Syndrome with a site in United States are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 8 Post-Lyme Disease Syndrome studies recruiting now, 5 set no upper age limit and 3 stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Post-Lyme Disease Syndrome with a site in United States, or all of them as a file.
02

Study summary

This is a mixed methods study exploring the experiences of pregnancy and parenting among participants with Lyme disease. Eligible participants will have been diagnosed with Lyme disease (LD), post-treatment Lyme disease syndrome (PTLDS), and/or chronic Lyme (CL) either during or before a prior pregnancy. Participants will complete quantitative surveys on topics such as their medical history, their child(ren)'s development, and demographic information. They will then participate in a qualitative interview where they will be asked about their experiences with pregnancy and with parenting their child(ren) in the context of their condition.

Read the detailed description

Patients with chronic conditions may experience the perinatal period and the experience of parenting differently than their healthy peers. The purpose of this study is to understand the lived experiences of pregnancy and parenting among gestational parents with Lyme disease.

Participants may be included in this study if they report having received a diagnosis of Lyme disease (LD), post-treatment Lyme disease syndrome (PTLDS), or chronic Lyme (CL) and they have given birth to at least one liveborn child. The investigators hypothesize that patients with LD/PTLDS/CL will experience unique challenges related to pregnancy, experiences in medical care settings, and their child's development.

Enrolled participants will complete a brief set of online quantitative questionnaires on topics such as their demographic characteristics, family information, Lyme disease histories, and mental health. The investigators will report on these data to illustrate similarities and differences between participants in the study for potentially relevant factors (e.g., timing of Lyme diagnosis relative to pregnancy, symptoms, mental health concerns). The questionnaires will be followed by an in-depth qualitative interview in English with each participant to learn about their experiences related to pregnancy and parenting with LD/PTLDS/CL, including specific questions about navigating the health care system, information seeking behaviors, and their child's development.

03

Conditions studied

  • Lyme Disease
  • Post Treatment Lyme Disease
  • Chronic Lyme Disease
  • Tick-Borne Infections
  • Tick-Borne Diseases
  • Pregnancy Complications
  • Parenting
04

In context

Post-Lyme Disease Syndrome Reclassified

22 studies on the registry are indexed under Post-Lyme Disease Syndrome; 9 are open to participants now.

Browse Post-Lyme Disease Syndrome studies →

Lead sponsor

Children's National Research Institute is the lead sponsor of 127 studies on the registry; 45 are open to participants now.

Compared within Post-Lyme Disease Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Lyme Disease. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

We will enroll up to 30 participants in this study, all of whom have been pregnant in the past and given birth to at least one liveborn child. There is no limit to the number of children a participant has, age of child(ren), or duration of Lyme-related symptoms.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Over 18 years of age and reside in the United States or Canada
  • Diagnosed with acute Lyme disease, PTLDS, and/or Chronic Lyme by a health care provider while they were pregnant OR PTLDS/CL prior to becoming pregnant with ongoing symptoms during pregnancy

Exclusion criteria

Exclusion Criteria:

  • Under 18 years of age
  • Live outside of the United States or Canada
  • Never been diagnosed with Lyme disease by a medical provider
  • Never been pregnant
  • Never given birth to a liveborn infant
  • Previously participated in a qualitative study about their experience with Lyme disease
  • Do not want to agree to having their interviews audio recorded
06

Study design

Observational model
Other
Time perspective
Other
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Gestational parents with Lyme disease

    Participants in this study will be enrolled following a screening call to assess their eligibility. All participants must report that they were diagnosed with acute Lyme disease, PTLDS, and/or Chronic Lyme by a health care provider while they were pregnant OR PTLDS/CL prior to becoming pregnant with ongoing symptoms during pregnancy. After being consented for the study, participants will then complete a set of online questionnaires and participate in a qualitative interview with a member of the research team.

    Other: Quantitative surveys and qualitative interview

Interventions

  • OtherQuantitative surveys and qualitative interview

    All participants will complete online surveys on topics including demographic and socioeconomic information, medical history (parent and child), pregnancy history, and mental health and well-being. They will then participate in a qualitative interview about their pregnancy and parenting experiences as gestational parents with Lyme disease.

07

What researchers measure

Primary outcomes

  1. Understand the lived experiences of pregnancy and parenting among gestational parents with LD, PTLDS, and/or CL

    Semi-structured qualitative interviews will be conducted with parents with LD, PTLDS, and/or CL to understand their lived experience. The interviewer will follow a structured interview guide about participants' Lyme disease history, pregnancy, parenting experience, relationships, and their priorities. The interviewer will ask open-ended questions to understand participants' context and allow participants to share what they feel is important to them.

    Time frame: 3/20/2024 - 3/1/2025

Secondary outcomes

  1. Edinburgh Postnatal Depression Scale (EPDS)

    Participants will complete the Edinburgh Postnatal Depression Scale (EPDS) prior to their qualitative interviews. The EPDS is a 10-question standardized postnatal depression screener.

    Time frame: 3/20/2024 - 3/1/2025

  2. General Anxiety Disorder-7 (GAD-7)

    Participants will complete the General Anxiety Disorder-7 (GAD-7) screener prior to their qualitative interviews. The GAD-7 is a 7-question standardized assessment that measures severity of anxiety symptoms.

    Time frame: 3/20/2024 - 3/1/2025

  3. Parenting Stress Index 4th Edition, Short Form (PSI-4 SF)

    Participants will complete the Parenting Stress Index 4th Edition, Short Form (PSI-4 SF) prior to their qualitative interviews. The PSI-4 SF is a standardized assessment that measures child and parent characteristics and stress experienced by a parent.

    Time frame: 3/20/2024 - 3/1/2025

  4. 36-Item Short Form Survey (SF-36)

    Participants will complete the36-Item Short Form Survey (SF-36) prior to their qualitative interviews. The SF-36 is a standardized quality of life assessment.

    Time frame: 3/20/2024 - 3/1/2025

  5. World Health Organization Disability Assessment Schedule (WHODAS 2.0)

    Participants will complete the WHO Disability Assessment Schedule (WHODAS 2.0) prior to their qualitative interviews. The WHODAS 2.0 is a 36-question standardized measure of health and disability.

    Time frame: 3/20/2024 - 3/1/2025

  6. Posttraumatic Diagnostic Scale (PDS-5)

    Participants will complete a modified version of the Posttraumatic Diagnostic Scale (PDS-5) prior to their qualitative interviews. The PDS-5 is a 24-question standardized measure of posttraumatic stress symptomatology. Participants will answer questions specific to their experience with Lyme disease.

    Time frame: 3/20/2024 - 3/1/2025

  7. Positive Affect and Well-Being Scale

    Participants will complete the Positive Affect and Well-Being Scale prior to their qualitative interviews. The Positive Affect and Well-Being Scale is a 9-item measure of participants' sense of well-being.

    Time frame: 3/20/2024 - 3/1/2025

08

Study locations

1 of 1 sites recruiting
09

References and documents

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2024 (actual). Primary completion is estimated for Dec 2026, 32 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2024
First posted
May 3, 2024
StartActual
Mar 20, 2024
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 2026
Last update
Jun 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06397794
Collaborators
Clinical Trials Network for Lyme and Other Tick-Borne Diseases, Steven & Alexandra Cohen Foundation
Responsible party
Sponsor
First posted
May 3, 2024
Start date
Mar 20, 2024
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jun 17, 2026

Study contacts

Meagan E Williams, MSPH, CCRC
Contact
mewilliams@childrensnational.org
202-476-3388
Sarah B. Mulkey, MD, PhD
Contact
sbmulkey@childrensnational.org
Sarah B. Mulkey, MD, PhD
principal investigator · Children's National Research Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion